vs
Brookfield Business Corp（BBUC）与Solventum（SOLV）财务数据对比。点击上方公司名可切换其他公司
Solventum的季度营收约是Brookfield Business Corp的1.1倍（$2.0B vs $1.9B），Solventum净利率更高（3.2% vs -1.2%，领先4.4%），Brookfield Business Corp同比增速更快（-3.6% vs -3.7%）
布鲁克菲尔德商业合伙有限合伙企业是一家公开上市的有限合伙企业，是母公司布鲁克菲尔德集团旗下私募股权投资板块商业服务与工业业务的主要公众持股平台，于2016年6月从布鲁克菲尔德资产管理公司分拆成立。
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
BBUC vs SOLV — 直观对比
营收规模更大
SOLV
是对方的1.1倍
$1.9B
营收增速更快
BBUC
高出0.1%
-3.7%
净利率更高
SOLV
高出4.4%
-1.2%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.9B | $2.0B |
| 净利润 | $-23.0M | $63.0M |
| 毛利率 | — | 51.4% |
| 营业利润率 | — | 6.3% |
| 净利率 | -1.2% | 3.2% |
| 营收同比 | -3.6% | -3.7% |
| 净利润同比 | -157.5% | 103.2% |
| 每股收益（稀释后） | — | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBUCSOLV
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | $1.9B | $2.2B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $1.9B | $2.1B | ||
| Q1 24 | — | $2.0B |
净利润BBUCSOLV
| Q4 25 | — | $63.0M | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | $-23.0M | $90.0M | ||
| Q1 25 | — | $137.0M | ||
| Q4 24 | — | $31.0M | ||
| Q3 24 | — | $122.0M | ||
| Q2 24 | $40.0M | $89.0M | ||
| Q1 24 | — | $237.0M |
毛利率BBUCSOLV
| Q4 25 | — | 51.4% | ||
| Q3 25 | — | 54.2% | ||
| Q2 25 | — | 54.4% | ||
| Q1 25 | — | 53.8% | ||
| Q4 24 | — | 53.9% | ||
| Q3 24 | — | 56.0% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 58.1% |
营业利润率BBUCSOLV
| Q4 25 | — | 6.3% | ||
| Q3 25 | — | 80.6% | ||
| Q2 25 | — | 9.9% | ||
| Q1 25 | — | 7.3% | ||
| Q4 24 | — | 6.6% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 11.7% | ||
| Q1 24 | — | 18.9% |
净利率BBUCSOLV
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 60.4% | ||
| Q2 25 | -1.2% | 4.2% | ||
| Q1 25 | — | 6.6% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | 2.1% | 4.3% | ||
| Q1 24 | — | 11.8% |
每股收益（稀释后）BBUCSOLV
| Q4 25 | — | $0.37 | ||
| Q3 25 | — | $7.22 | ||
| Q2 25 | — | $0.51 | ||
| Q1 25 | — | $0.78 | ||
| Q4 24 | — | $0.18 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $0.51 | ||
| Q1 24 | — | $1.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $613.0M | $878.0M |
| 总债务越低越好 | — | $5.0B |
| 股东权益账面价值 | $2.6B | $5.0B |
| 总资产 | $16.3B | $14.3B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资BBUCSOLV
| Q4 25 | — | $878.0M | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | $613.0M | $492.0M | ||
| Q1 25 | — | $534.0M | ||
| Q4 24 | — | $762.0M | ||
| Q3 24 | — | $772.0M | ||
| Q2 24 | $754.0M | $897.0M | ||
| Q1 24 | — | $996.0M |
总债务BBUCSOLV
| Q4 25 | — | $5.0B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | — | $7.8B | ||
| Q1 25 | — | $7.9B | ||
| Q4 24 | — | $8.0B | ||
| Q3 24 | — | $8.1B | ||
| Q2 24 | — | $8.3B | ||
| Q1 24 | — | $8.3B |
股东权益BBUCSOLV
| Q4 25 | — | $5.0B | ||
| Q3 25 | — | $5.0B | ||
| Q2 25 | $2.6B | $3.6B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | $4.6B | $2.9B | ||
| Q1 24 | — | $3.9B |
总资产BBUCSOLV
| Q4 25 | — | $14.3B | ||
| Q3 25 | — | $14.0B | ||
| Q2 25 | $16.3B | $15.1B | ||
| Q1 25 | — | $14.5B | ||
| Q4 24 | — | $14.5B | ||
| Q3 24 | — | $14.7B | ||
| Q2 24 | $20.5B | $14.6B | ||
| Q1 24 | — | $14.7B |
负债/权益比BBUCSOLV
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 2.14× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | 2.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $95.0M |
| 自由现金流经营现金流 - 资本支出 | — | $32.0M |
| 自由现金流率自由现金流/营收 | — | 1.6% |
| 资本支出强度资本支出/营收 | — | 3.2% |
| 现金转化率经营现金流/净利润 | — | 1.51× |
| 过去12个月自由现金流最近4个季度 | — | $-10.0M |
8季度趋势，按日历期对齐
经营现金流BBUCSOLV
| Q4 25 | — | $95.0M | ||
| Q3 25 | — | $76.0M | ||
| Q2 25 | — | $169.0M | ||
| Q1 25 | — | $29.0M | ||
| Q4 24 | — | $219.0M | ||
| Q3 24 | — | $169.0M | ||
| Q2 24 | — | $355.0M | ||
| Q1 24 | — | $442.0M |
自由现金流BBUCSOLV
| Q4 25 | — | $32.0M | ||
| Q3 25 | — | $-21.0M | ||
| Q2 25 | — | $59.0M | ||
| Q1 25 | — | $-80.0M | ||
| Q4 24 | — | $92.0M | ||
| Q3 24 | — | $76.0M | ||
| Q2 24 | — | $297.0M | ||
| Q1 24 | — | $340.0M |
自由现金流率BBUCSOLV
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | -1.0% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | -3.9% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 14.3% | ||
| Q1 24 | — | 16.9% |
资本支出强度BBUCSOLV
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 5.1% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 5.1% |
现金转化率BBUCSOLV
| Q4 25 | — | 1.51× | ||
| Q3 25 | — | 0.06× | ||
| Q2 25 | — | 1.88× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 7.06× | ||
| Q3 24 | — | 1.39× | ||
| Q2 24 | — | 3.99× | ||
| Q1 24 | — | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBUC
暂无分部数据
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
